BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 27684792)

  • 1. Halitosis and helicobacter pylori infection: A meta-analysis.
    Dou W; Li J; Xu L; Zhu J; Hu K; Sui Z; Wang J; Xu L; Wang S; Yin G
    Medicine (Baltimore); 2016 Sep; 95(39):e4223. PubMed ID: 27684792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Eradication therapy in Helicobacter pylori-positive patients with halitosis: long-term outcome.
    Katsinelos P; Tziomalos K; Chatzimavroudis G; Vasiliadis T; Katsinelos T; Pilpilidis I; Triantafillidis I; Paroutoglou G; Papaziogas B
    Med Princ Pract; 2007; 16(2):119-23. PubMed ID: 17303947
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fluoroquinolone Sequential Therapy for Helicobacter pylori: A Meta-analysis.
    Kale-Pradhan PB; Mihaescu A; Wilhelm SM
    Pharmacotherapy; 2015 Aug; 35(8):719-30. PubMed ID: 26173786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Changes in halitosis value before and after Helicobacter pylori eradication: A single-institutional prospective study.
    Kudo Y; Kudo SE; Miyachi H; Ichimasa K; Ogawa Y; Kouyama Y; Sakurai T; Ikeda M; Saito Y; Kamada T; Gotoda T
    J Gastroenterol Hepatol; 2022 May; 37(5):928-932. PubMed ID: 35324036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Indications for treatment of Helicobacter pylori infection: a systematic overview.
    Veldhuyzen van Zanten SJ; Sherman PM
    CMAJ; 1994 Jan; 150(2):189-98. PubMed ID: 8287341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Meta-analysis: is sequential therapy superior to standard triple therapy for Helicobacter pylori infection in Asian adults?
    Yoon H; Lee DH; Kim N; Park YS; Shin CM; Kang KK; Oh DH; Jang DK; Chung JW
    J Gastroenterol Hepatol; 2013 Dec; 28(12):1801-9. PubMed ID: 24118110
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Meta-analysis: eradication of Helicobacter pylori infection is associated with the development of endoscopic gastroesophageal reflux disease.
    Xie T; Cui X; Zheng H; Chen D; He L; Jiang B
    Eur J Gastroenterol Hepatol; 2013 Oct; 25(10):1195-205. PubMed ID: 23839160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is Helicobacter pylori infection associated with glycemic control in diabetics?
    Dai YN; Yu WL; Zhu HT; Ding JX; Yu CH; Li YM
    World J Gastroenterol; 2015 May; 21(17):5407-16. PubMed ID: 25954115
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of Helicobacter pylori eradication on hyperplastic gastric polyps: A systematic review and meta-analysis.
    Ouyang Y; Zhang W; Huang Y; Wang Y; Shao Q; Wu X; Lu N; Xie C
    Helicobacter; 2021 Oct; 26(5):e12838. PubMed ID: 34333811
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of CYP2C19 genetic polymorphisms on the efficacy of proton pump inhibitor-based triple therapy for Helicobacter pylori eradication: a meta-analysis.
    Zhao F; Wang J; Yang Y; Wang X; Shi R; Xu Z; Huang Z; Zhang G
    Helicobacter; 2008 Dec; 13(6):532-41. PubMed ID: 19166419
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Paediatric Halitosis and Helicobacter pylori Infection.
    Yilmaz AE; Bilici M; Tonbul A; Karabel M; Dogan G; Tas T
    J Coll Physicians Surg Pak; 2012 Jan; 22(1):27-30. PubMed ID: 22237186
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Systematic review with meta-analysis: Saccharomyces boulardii supplementation and eradication of Helicobacter pylori infection.
    Szajewska H; Horvath A; Kołodziej M
    Aliment Pharmacol Ther; 2015 Jun; 41(12):1237-45. PubMed ID: 25898944
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meta-analysis: the effect of supplementation with probiotics on eradication rates and adverse events during Helicobacter pylori eradication therapy.
    Tong JL; Ran ZH; Shen J; Zhang CX; Xiao SD
    Aliment Pharmacol Ther; 2007 Jan; 25(2):155-68. PubMed ID: 17229240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Meta-analysis: sequential therapy for Helicobacter pylori eradication in children.
    Horvath A; Dziechciarz P; Szajewska H
    Aliment Pharmacol Ther; 2012 Sep; 36(6):534-41. PubMed ID: 22827718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced symptoms and need for antisecretory therapy in veterans 3 years after Helicobacter pylori eradication with ranitidine bismuth citrate/amoxicillin/clarithromycin.
    Sontag SJ; O'Connell S; Schnell T; Chejfec G; Seidel J; Sonnenberg A
    Am J Gastroenterol; 2001 May; 96(5):1390-5. PubMed ID: 11374672
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of moxifloxacin-based sequential therapy for first-line eradication of Helicobacter pylori infection in gastrointestinal disease.
    Hwang JJ; Lee DH; Lee AR; Yoon H; Shin CM; Park YS; Kim N
    World J Gastroenterol; 2015 Apr; 21(16):5032-8. PubMed ID: 25945019
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Meta-analysis: the effect of supplementation with lactoferrin on eradication rates and adverse events during Helicobacter pylori eradication therapy.
    Zou J; Dong J; Yu XF
    Helicobacter; 2009 Apr; 14(2):119-27. PubMed ID: 19298339
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Eradication of Helicobacter pylori with triple therapy: an epidemiologic analysis of trends in Turkey over 10 years.
    Kadayifci A; Buyukhatipoglu H; Cemil Savas M; Simsek I
    Clin Ther; 2006 Nov; 28(11):1960-6. PubMed ID: 17213016
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Korea red ginseng on Helicobacter pylori-induced halitosis: newer therapeutic strategy and a plausible mechanism.
    Lee JS; Kwon KA; Jung HS; Kim JH; Hahm KB
    Digestion; 2009; 80(3):192-9. PubMed ID: 19776584
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Halitosis: Helicobacter pylori or oral factors.
    Anbari F; Ashouri Moghaddam A; Sabeti E; Khodabakhshi A
    Helicobacter; 2019 Feb; 24(1):e12556. PubMed ID: 30440100
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.